 Heidi Day
Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypothalamo-Hypophyseal System | 23 | 2019 | 198 | 1.760 |
Why?
| | Pituitary-Adrenal System | 22 | 2019 | 165 | 1.660 |
Why?
| | Stress, Psychological | 26 | 2019 | 1153 | 1.500 |
Why?
| | Stress, Physiological | 13 | 2019 | 453 | 1.240 |
Why?
| | RNA, Messenger | 30 | 2017 | 2832 | 1.210 |
Why?
| | Corticosterone | 25 | 2019 | 244 | 1.200 |
Why?
| | Amygdala | 11 | 2018 | 198 | 1.180 |
Why?
| | Receptors, Adrenergic, alpha-1 | 6 | 2010 | 45 | 1.130 |
Why?
| | Proto-Oncogene Proteins c-fos | 21 | 2019 | 196 | 1.110 |
Why?
| | Habituation, Psychophysiologic | 10 | 2014 | 58 | 1.000 |
Why?
| | Rats, Sprague-Dawley | 44 | 2019 | 2540 | 0.860 |
Why?
| | Rats | 57 | 2019 | 5614 | 0.860 |
Why?
| | Adrenocorticotropic Hormone | 18 | 2019 | 147 | 0.670 |
Why?
| | Corticotropin-Releasing Hormone | 6 | 2018 | 72 | 0.640 |
Why?
| | Motor Activity | 10 | 2015 | 722 | 0.630 |
Why?
| | Noise | 11 | 2016 | 71 | 0.620 |
Why?
| | Gene Expression Regulation | 12 | 2011 | 2609 | 0.600 |
Why?
| | Fear | 7 | 2018 | 366 | 0.590 |
Why?
| | Running | 6 | 2014 | 228 | 0.520 |
Why?
| | Amphetamine | 8 | 2008 | 38 | 0.500 |
Why?
| | Raphe Nuclei | 5 | 2019 | 111 | 0.470 |
Why?
| | In Situ Hybridization | 17 | 2012 | 319 | 0.470 |
Why?
| | Acoustic Stimulation | 12 | 2015 | 334 | 0.450 |
Why?
| | Genes, fos | 4 | 2004 | 37 | 0.420 |
Why?
| | Conditioning, Classical | 4 | 2017 | 120 | 0.410 |
Why?
| | Septal Nuclei | 4 | 2018 | 23 | 0.410 |
Why?
| | Thalamus | 2 | 2009 | 126 | 0.400 |
Why?
| | Restraint, Physical | 10 | 2019 | 75 | 0.390 |
Why?
| | Analysis of Variance | 13 | 2011 | 1311 | 0.390 |
Why?
| | Paraventricular Hypothalamic Nucleus | 7 | 2019 | 33 | 0.370 |
Why?
| | Receptor, Serotonin, 5-HT1A | 5 | 2019 | 36 | 0.370 |
Why?
| | Animals | 62 | 2019 | 38109 | 0.360 |
Why?
| | Physical Conditioning, Animal | 5 | 2015 | 243 | 0.340 |
Why?
| | Brain | 12 | 2018 | 2941 | 0.330 |
Why?
| | Dentate Gyrus | 2 | 2010 | 40 | 0.330 |
Why?
| | Interleukin-1 | 4 | 2000 | 961 | 0.320 |
Why?
| | Hippocampus | 6 | 2012 | 967 | 0.290 |
Why?
| | Behavior, Animal | 12 | 2009 | 520 | 0.270 |
Why?
| | Corpus Striatum | 4 | 2015 | 179 | 0.270 |
Why?
| | Receptors, Cholecystokinin | 2 | 1999 | 9 | 0.260 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 2 | 2019 | 28 | 0.250 |
Why?
| | Extinction, Psychological | 3 | 2017 | 92 | 0.250 |
Why?
| | Male | 58 | 2019 | 72406 | 0.240 |
Why?
| | Adrenal Glands | 5 | 2019 | 77 | 0.240 |
Why?
| | Receptor, Cannabinoid, CB1 | 2 | 2019 | 39 | 0.240 |
Why?
| | Neurotensin | 2 | 2002 | 13 | 0.230 |
Why?
| | Cocaine | 3 | 2001 | 161 | 0.220 |
Why?
| | Environment | 6 | 2003 | 305 | 0.220 |
Why?
| | Anti-Inflammatory Agents | 1 | 2008 | 475 | 0.210 |
Why?
| | Reflex, Startle | 5 | 2018 | 76 | 0.210 |
Why?
| | Thiazoles | 1 | 2004 | 136 | 0.210 |
Why?
| | Neural Inhibition | 1 | 2005 | 178 | 0.200 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 6 | 2011 | 851 | 0.200 |
Why?
| | Central Nervous System Stimulants | 4 | 2008 | 185 | 0.200 |
Why?
| | Neurons | 7 | 2015 | 1642 | 0.190 |
Why?
| | Sympathectomy, Chemical | 1 | 2002 | 5 | 0.190 |
Why?
| | Helplessness, Learned | 3 | 2016 | 67 | 0.180 |
Why?
| | Neostriatum | 1 | 2002 | 37 | 0.180 |
Why?
| | Dopamine | 2 | 2002 | 289 | 0.180 |
Why?
| | Gene Expression | 7 | 2018 | 1490 | 0.180 |
Why?
| | Tryptophan Hydroxylase | 2 | 2019 | 54 | 0.180 |
Why?
| | Odorants | 5 | 2009 | 116 | 0.170 |
Why?
| | Heart Rate | 3 | 2016 | 855 | 0.160 |
Why?
| | Neuroendocrine Cells | 1 | 2019 | 33 | 0.150 |
Why?
| | Smell | 4 | 2009 | 128 | 0.150 |
Why?
| | Serotonin | 4 | 2019 | 294 | 0.150 |
Why?
| | Olfactory Pathways | 2 | 2009 | 38 | 0.140 |
Why?
| | Sex Characteristics | 3 | 2014 | 791 | 0.140 |
Why?
| | Mycobacteriaceae | 1 | 2018 | 35 | 0.140 |
Why?
| | Ferrets | 5 | 2009 | 31 | 0.140 |
Why?
| | Rats, Inbred F344 | 6 | 2016 | 268 | 0.140 |
Why?
| | Escape Reaction | 2 | 2009 | 56 | 0.130 |
Why?
| | Autonomic Nervous System | 2 | 2016 | 79 | 0.130 |
Why?
| | Vaccines, Inactivated | 1 | 2017 | 70 | 0.130 |
Why?
| | Bacterial Vaccines | 1 | 2017 | 63 | 0.130 |
Why?
| | Brain Chemistry | 1 | 1997 | 116 | 0.130 |
Why?
| | Lactoferrin | 1 | 2016 | 36 | 0.120 |
Why?
| | Nucleus Raphe Pallidus | 1 | 2016 | 2 | 0.120 |
Why?
| | Prebiotics | 1 | 2016 | 28 | 0.120 |
Why?
| | Oxidopamine | 5 | 2003 | 14 | 0.120 |
Why?
| | Hypothalamus, Posterior | 1 | 2016 | 3 | 0.120 |
Why?
| | Mycobacterium | 1 | 2017 | 116 | 0.120 |
Why?
| | Prosencephalon | 2 | 2008 | 53 | 0.120 |
Why?
| | Radioimmunoassay | 3 | 2010 | 165 | 0.120 |
Why?
| | Enkephalins | 3 | 2014 | 21 | 0.110 |
Why?
| | Time Factors | 8 | 2011 | 7183 | 0.110 |
Why?
| | Adrenalectomy | 2 | 2008 | 71 | 0.110 |
Why?
| | Cholecystokinin | 1 | 1994 | 15 | 0.110 |
Why?
| | Spinal Cord | 1 | 1997 | 382 | 0.110 |
Why?
| | Genes, Immediate-Early | 1 | 1994 | 26 | 0.110 |
Why?
| | Muscimol | 2 | 2016 | 23 | 0.100 |
Why?
| | Hypothalamus | 4 | 2019 | 153 | 0.100 |
Why?
| | Catecholamines | 2 | 2004 | 87 | 0.100 |
Why?
| | Preoptic Area | 1 | 2013 | 8 | 0.100 |
Why?
| | Transcription, Genetic | 1 | 1999 | 1496 | 0.100 |
Why?
| | Electroshock | 2 | 2014 | 145 | 0.100 |
Why?
| | Receptor, Serotonin, 5-HT2C | 1 | 2012 | 14 | 0.090 |
Why?
| | Body Temperature | 2 | 2011 | 229 | 0.090 |
Why?
| | Estradiol | 2 | 2013 | 533 | 0.090 |
Why?
| | Auditory Cortex | 1 | 2012 | 47 | 0.090 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2016 | 148 | 0.090 |
Why?
| | Auditory Pathways | 2 | 2009 | 53 | 0.090 |
Why?
| | Prefrontal Cortex | 3 | 2016 | 328 | 0.080 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 3 | 2019 | 62 | 0.080 |
Why?
| | Escherichia coli Infections | 1 | 2011 | 129 | 0.080 |
Why?
| | gamma-Aminobutyric Acid | 2 | 2004 | 193 | 0.080 |
Why?
| | Dopamine Uptake Inhibitors | 2 | 2001 | 59 | 0.080 |
Why?
| | Limbic System | 1 | 2010 | 55 | 0.080 |
Why?
| | Receptors, Dopamine D2 | 3 | 2014 | 93 | 0.080 |
Why?
| | Conditioning, Operant | 1 | 2010 | 99 | 0.080 |
Why?
| | Nerve Growth Factors | 1 | 2010 | 78 | 0.080 |
Why?
| | Memory Disorders | 1 | 2011 | 194 | 0.080 |
Why?
| | Astrocytes | 1 | 2012 | 224 | 0.080 |
Why?
| | Anxiety | 2 | 2018 | 1110 | 0.080 |
Why?
| | Olfactory Perception | 1 | 2009 | 18 | 0.080 |
Why?
| | Microglia | 1 | 2012 | 269 | 0.080 |
Why?
| | GABA Agonists | 1 | 2009 | 24 | 0.070 |
Why?
| | Diet | 1 | 2016 | 1275 | 0.070 |
Why?
| | Dose-Response Relationship, Radiation | 2 | 2008 | 140 | 0.070 |
Why?
| | Organic Cation Transport Proteins | 2 | 2019 | 25 | 0.070 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 863 | 0.070 |
Why?
| | Pheromones | 1 | 2008 | 22 | 0.070 |
Why?
| | Catheterization | 1 | 2009 | 183 | 0.070 |
Why?
| | Reward | 1 | 2010 | 247 | 0.070 |
Why?
| | Neuronal Plasticity | 1 | 2010 | 309 | 0.070 |
Why?
| | Injections, Intraperitoneal | 2 | 1999 | 117 | 0.070 |
Why?
| | Devazepide | 2 | 1999 | 4 | 0.060 |
Why?
| | Receptors, Dopamine D1 | 2 | 2014 | 35 | 0.060 |
Why?
| | Receptors, Catecholamine | 1 | 2006 | 4 | 0.060 |
Why?
| | Cell Count | 2 | 2009 | 321 | 0.060 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2006 | 93 | 0.060 |
Why?
| | Immunization | 2 | 2018 | 374 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2006 | 2032 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 1999 | 1371 | 0.060 |
Why?
| | Neural Pathways | 3 | 2015 | 311 | 0.060 |
Why?
| | Sympatholytics | 2 | 2002 | 11 | 0.060 |
Why?
| | Caffeine | 1 | 2006 | 74 | 0.060 |
Why?
| | Receptor, Serotonin, 5-HT1B | 1 | 2005 | 6 | 0.060 |
Why?
| | Avoidance Learning | 1 | 2005 | 65 | 0.060 |
Why?
| | Association Learning | 1 | 2005 | 71 | 0.060 |
Why?
| | Foxes | 1 | 2004 | 3 | 0.060 |
Why?
| | Early Growth Response Protein 1 | 1 | 2005 | 32 | 0.050 |
Why?
| | Physical Endurance | 1 | 2006 | 278 | 0.050 |
Why?
| | Immediate-Early Proteins | 1 | 2005 | 48 | 0.050 |
Why?
| | Tissue Distribution | 3 | 2005 | 334 | 0.050 |
Why?
| | Caudate Nucleus | 2 | 2001 | 21 | 0.050 |
Why?
| | Piperidines | 2 | 2019 | 217 | 0.050 |
Why?
| | Body Weight | 5 | 2011 | 978 | 0.050 |
Why?
| | Depression | 2 | 2012 | 1559 | 0.050 |
Why?
| | Nitric Oxide | 2 | 2000 | 897 | 0.050 |
Why?
| | Immunohistochemistry | 4 | 2009 | 1718 | 0.050 |
Why?
| | Fatigue | 1 | 2006 | 366 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2005 | 154 | 0.050 |
Why?
| | Androstanols | 1 | 2003 | 30 | 0.050 |
Why?
| | Nucleus Accumbens | 2 | 2001 | 135 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 983 | 0.050 |
Why?
| | Basal Ganglia | 1 | 2003 | 57 | 0.050 |
Why?
| | Random Allocation | 2 | 2014 | 363 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2005 | 496 | 0.050 |
Why?
| | Pyrazoles | 2 | 2019 | 510 | 0.050 |
Why?
| | Receptors, Glucocorticoid | 1 | 2003 | 138 | 0.050 |
Why?
| | Nitric Oxide Synthase | 2 | 2000 | 235 | 0.040 |
Why?
| | Aging | 2 | 2011 | 1966 | 0.040 |
Why?
| | Sympathetic Nervous System | 1 | 2003 | 178 | 0.040 |
Why?
| | Apomorphine | 1 | 2001 | 6 | 0.040 |
Why?
| | Neocortex | 1 | 2001 | 49 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 592 | 0.040 |
Why?
| | Microinjections | 1 | 2001 | 92 | 0.040 |
Why?
| | Inflammation | 1 | 2012 | 2880 | 0.040 |
Why?
| | Injections, Intraventricular | 2 | 2000 | 58 | 0.040 |
Why?
| | Subthalamic Nucleus | 1 | 2001 | 83 | 0.040 |
Why?
| | Encephalomyelitis | 1 | 2000 | 14 | 0.040 |
Why?
| | Neurosecretory Systems | 1 | 2019 | 31 | 0.040 |
Why?
| | Adrenal Cortex | 1 | 2019 | 33 | 0.040 |
Why?
| | Pro-Opiomelanocortin | 1 | 1999 | 20 | 0.040 |
Why?
| | Maternal Deprivation | 1 | 2019 | 16 | 0.040 |
Why?
| | Meglumine | 1 | 1999 | 18 | 0.040 |
Why?
| | Dorsal Raphe Nucleus | 1 | 2019 | 31 | 0.040 |
Why?
| | Serotonergic Neurons | 1 | 2019 | 29 | 0.040 |
Why?
| | Endocannabinoids | 1 | 2019 | 57 | 0.040 |
Why?
| | Methamphetamine | 1 | 1979 | 71 | 0.040 |
Why?
| | Neuropeptides | 1 | 2018 | 77 | 0.040 |
Why?
| | Area Under Curve | 1 | 1999 | 331 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1500 | 0.030 |
Why?
| | Models, Biological | 1 | 2005 | 1822 | 0.030 |
Why?
| | Nicotine | 1 | 1979 | 332 | 0.030 |
Why?
| | Transcription Factors | 1 | 2005 | 1742 | 0.030 |
Why?
| | GABA-A Receptor Agonists | 1 | 2016 | 17 | 0.030 |
Why?
| | Exercise Test | 2 | 2011 | 634 | 0.030 |
Why?
| | Pituitary Gland | 1 | 1996 | 148 | 0.030 |
Why?
| | Indoles | 1 | 1999 | 501 | 0.030 |
Why?
| | Dynorphins | 1 | 2014 | 8 | 0.030 |
Why?
| | Receptor, Adenosine A1 | 1 | 2014 | 11 | 0.030 |
Why?
| | Vagotomy | 1 | 1994 | 33 | 0.030 |
Why?
| | Benzodiazepinones | 1 | 1994 | 18 | 0.030 |
Why?
| | Receptor, Adenosine A2A | 1 | 2014 | 23 | 0.030 |
Why?
| | Proestrus | 1 | 2013 | 2 | 0.030 |
Why?
| | Oxytocin | 1 | 1994 | 51 | 0.030 |
Why?
| | Brain Stem | 1 | 1994 | 96 | 0.030 |
Why?
| | Proteins | 1 | 1999 | 1022 | 0.020 |
Why?
| | Acute Disease | 1 | 2016 | 1031 | 0.020 |
Why?
| | Kinetics | 1 | 1996 | 1629 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3125 | 0.020 |
Why?
| | Rats, Inbred BN | 1 | 2011 | 55 | 0.020 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2012 | 87 | 0.020 |
Why?
| | Receptors, Opioid, delta | 1 | 2010 | 10 | 0.020 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2010 | 71 | 0.020 |
Why?
| | Environment, Controlled | 1 | 2010 | 23 | 0.020 |
Why?
| | Base Sequence | 1 | 1994 | 2191 | 0.020 |
Why?
| | Female | 6 | 2019 | 78376 | 0.020 |
Why?
| | Zinc Sulfate | 1 | 2009 | 8 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2012 | 395 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 276 | 0.020 |
Why?
| | Vomeronasal Organ | 1 | 2009 | 8 | 0.020 |
Why?
| | Ibotenic Acid | 1 | 2009 | 5 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1994 | 2931 | 0.020 |
Why?
| | Dominance-Subordination | 1 | 2009 | 16 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 902 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5417 | 0.020 |
Why?
| | Olfaction Disorders | 1 | 2009 | 70 | 0.020 |
Why?
| | Periodicity | 1 | 2008 | 58 | 0.020 |
Why?
| | Scent Glands | 1 | 2008 | 2 | 0.020 |
Why?
| | Housing, Animal | 1 | 2008 | 46 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5997 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 463 | 0.020 |
Why?
| | Thymus Gland | 1 | 2008 | 311 | 0.020 |
Why?
| | Nerve Net | 1 | 2010 | 285 | 0.020 |
Why?
| | Biogenic Monoamines | 1 | 2006 | 15 | 0.020 |
Why?
| | Gyrus Cinguli | 1 | 2006 | 96 | 0.020 |
Why?
| | Sex Factors | 1 | 2012 | 2114 | 0.010 |
Why?
| | Electric Stimulation | 1 | 2006 | 276 | 0.010 |
Why?
| | Weight Gain | 1 | 2008 | 559 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2012 | 4155 | 0.010 |
Why?
| | RNA, Heterogeneous Nuclear | 1 | 2003 | 6 | 0.010 |
Why?
| | Environmental Exposure | 1 | 2008 | 590 | 0.010 |
Why?
| | Up-Regulation | 1 | 2006 | 852 | 0.010 |
Why?
| | Receptors, Serotonin, 5-HT1 | 1 | 2003 | 8 | 0.010 |
Why?
| | Receptors, Serotonin | 1 | 2003 | 35 | 0.010 |
Why?
| | AIDS-Related Complex | 1 | 2003 | 4 | 0.010 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2003 | 14 | 0.010 |
Why?
| | Drug Administration Routes | 1 | 2003 | 44 | 0.010 |
Why?
| | Rotation | 1 | 2003 | 121 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2006 | 1137 | 0.010 |
Why?
| | Mice | 1 | 2019 | 18365 | 0.010 |
Why?
| | Parietal Lobe | 1 | 2001 | 60 | 0.010 |
Why?
| | Drug Interactions | 1 | 2003 | 401 | 0.010 |
Why?
| | Emotions | 1 | 2006 | 578 | 0.010 |
Why?
| | Adaptation, Psychological | 1 | 2006 | 717 | 0.010 |
Why?
| | Spleen | 1 | 2003 | 508 | 0.010 |
Why?
| | Receptors, Corticotropin | 1 | 1999 | 2 | 0.010 |
Why?
| | Receptor, Melanocortin, Type 3 | 1 | 1999 | 2 | 0.010 |
Why?
| | Agouti-Related Protein | 1 | 1999 | 3 | 0.010 |
Why?
| | Receptor, Melanocortin, Type 4 | 1 | 1999 | 17 | 0.010 |
Why?
| | Autoradiography | 1 | 1999 | 65 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2010 | 4569 | 0.010 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2000 | 162 | 0.010 |
Why?
| | Life Expectancy | 1 | 1979 | 72 | 0.010 |
Why?
| | Nerve Fibers | 1 | 1999 | 104 | 0.010 |
Why?
| | Microdialysis | 1 | 1998 | 56 | 0.010 |
Why?
| | Sodium Chloride | 1 | 1979 | 142 | 0.010 |
Why?
| | Neoplasms, Experimental | 1 | 1979 | 173 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 1999 | 381 | 0.010 |
Why?
| | Feedback | 1 | 1998 | 181 | 0.010 |
Why?
| | Cerebral Cortex | 1 | 1998 | 465 | 0.010 |
Why?
| | Fetus | 1 | 1979 | 803 | 0.010 |
Why?
| | Glucocorticoids | 1 | 1998 | 535 | 0.010 |
Why?
| | Age Factors | 1 | 1979 | 3335 | 0.010 |
Why?
| | Humans | 3 | 1999 | 144957 | 0.010 |
Why?
| | Pregnancy | 1 | 1979 | 7191 | 0.000 |
Why?
|
|
Day's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|